我們對超過一百萬種化合物的分子庫進行了完整的運算篩選。也針對所有已上市產品的化合物進行測試，希望能為患者找到潛在的治療方法。同時，我們參與了可以中和病毒的 SARS-CoV-2 抗體的研究和開發，以及染疫病人血栓預防的療法開發。

We conducted computational screening of our entire molecule library of more than one million compounds. Existing compounds from our current pipeline and portfolio were also tested as potential treatments for patients. We are involved in the research and development of SARS-CoV-2 antibodies that can neutralize the virus and the development of therapies to prevent blood clots.

了解更多持續對抗新冠肺炎的消息

Learn more about our ongoing engagement in the fight against COVID-19.​​